Adrenal gland- EMA negative adrenocortical adenoma.
Adrenal gland- EMA negative adrenocortical carcinoma.
Breast- Invasive breast cancer of no special type (NST) with strong EMA immunostaining of tumor cells.
Breast- Invasive lobular breast cancer with strong EMA immunostaining of tumor cells. Note: Staining is equally strong in normal glands.
Colon- Colorectal adenocarcinoma showing a weak EMA staining of only a few tumor cells.
Esophagus- Adenocarcinoma with strong EMA immunostaining of tumor cells.
Esophagus- Squamous cell carcinoma with strong EMA immunostaining of tumor cells.
Kidney- Chromophobe renal cell carcinoma with strong EMA immunostaining of tumor cells.
Kidney- Clear cell renal cell carcinoma with weak to moderate EMA immunostaining of tumor cells.
Kidney- EMA negative clear cell renal cell carcinoma.
Kidney- Papillary renal cell carcinoma showing moderate membranous EMA immunostaining of tumor cells.
Lung- Adenocarcinoma with a very intense cytoplasmic EMA staining of tumor cells. In addition: Contamination staining of the tumor adjacent stroma due to the very high quantitity of EMA protein in these tumor cells.
Lung- Adenocarcinoma with strong membranous and cytoplasmic EMA immunostaining of tumor cells.
Lung- Epitheloid variant of a malignant mesothelioma with strong, predominantly membranous EMA immunostaining of tumor cells.
Lung- Malignant mesothelioma (epitheloid variant) with strong, predominantly membranous EMA immunostaining of tumor cells.
Lung- Small cell carcinoma with strong EMA immunostaining of tumor cells.
Lymph node- Diffuse large B-cell lymphoma with a moderate EMA immunostaining of tumor cells.
Lymph node- EMA negative diffuse large B-cell lymphoma.
Ovary- Brenner tumor showing a weak to moderate EMA immunostaining of tumor cells.
Ovary- Serous high-grade carcinoma with strong EMA immunostaining of tumor cells.
Pancreas- Ductal adenocarcinoma showing a strong EMA staining of tumor cells.
Pancreas- EMA negative neuroendocrine tumor.
Penis- Squamous cell carcinoma exhibiting a strong EMA positivity of tumor cells.
Prostate- Adenocarcinoma (Gleason 5+5=10) with strong EMA immunostaining of tumor cells.
Prostate- EMA negative adenocarcinoma (Gleason 3+3=6).
Prostate- EMA negative small cell carcinoma.
Salivary gland- Warthin tumor showing strong EMA positivity, especially in basal cell layers.
Soft tissue- Sarcoma NOS with EMA immunostaining of variable intensity (weak to strong) in the majority of tumor cells.
Stomach- EMA negative gastrointestinal stromal tumor (GIST).
Stomach- Gastric adenocarcinoma (diffuse type) with variable intensity EMA immunostaining of most tumor cells.
Testis- EMA negative seminoma.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong EMA positivity of tumor cells.
Uterus, cervix- Squamous cell carcinoma with strong EMA staining in >90% of tumor cells